help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2009-0769
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Westholm, D. E.
Right arrow Articles by Anderson, G. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westholm, D. E.
Right arrow Articles by Anderson, G. W.
Endocrinology Vol. 150, No. 11 5153-5162
Copyright © 2009 by The Endocrine Society

The Blood-Brain Barrier Thyroxine Transporter Organic Anion-Transporting Polypeptide 1c1 Displays Atypical Transport Kinetics

Daniel E. Westholm, David R. Salo, Kevin J. Viken, Jon N. Rumbley1 and Grant W. Anderson1

Department of Pharmacy Practice and Pharmaceutical Sciences (D.E.W., D.R.S., K.J.V., J.N.R., G.W.A.), College of Pharmacy, University of Minnesota-Duluth, Duluth, Minnesota 55812

Address all correspondence and requests for reprints to: Grant W. Anderson, 232 Life Science, 1110 Kirby Drive, Duluth Minnesota 55812. E-mail: ander163{at}umn.edu.

Organic anion-transporting polypeptide (Oatp) 1c1 is a high-affinity T4 transporter expressed in brain barrier cells. Oatp1c1 transports a variety of additional ligands including the conjugated sterol estradiol 17β-glucuronide (E217βG). Intriguingly, published data suggest that E217βG inhibition of Oatp1c1-mediated T4 transport exhibits characteristics suggestive of atypical transport kinetics. To determine whether Oatp1c1 exhibits atypical transport kinetics, we first performed detailed T4 and E217βG uptake assays using Oatp1c1 stably transfected HEK293 cells and a wide range of T4 and E217βG concentrations (100 pM to 300 nM and 27 nM to 200 µM, respectively). Eadie-Hofstee plots derived from these detailed T4 and E217βG uptake experiments display a biphasic profile consistent with atypical transport kinetics. These data along with T4 and E217βG cis-inhibition dose-response measurements revealed shared high- and low-affinity Oatp1c1 binding sites for T4 and E217βG. T4 and E217βG recognized these Oatp1c1 binding sites with opposite preferences. In addition, sterols glucuronidated in the 17 or 21 position, exhibited preferential substrate-dependent inhibition of Oatp1c1 transport, inhibiting Oatp1c1-mediated E217βG transport more strongly than T4 transport. Together these data reveal that Oatp1c1-dependent substrate transport is a complex process involving substrate interaction with multiple binding sites and competition for binding with a variety of other substrates. A thorough understanding of atypical Oatp1c1 transport processes and substrate-dependent inhibition will allow better prediction of endo- and xenobiotic interactions with the Oatp transporter.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society